Designed to work with an implantable weight loss management system, the abiliti system, the LGL102 lead simplifies the system’s implantation and minimizes procedure time.

The LGL102 lead also simplifies the attachment of the food sensor and stimulation electrodes to the abdomen.

The principal investigator in the LGL102 clinical study Thomas Horbach said that with the new lead, the implantation procedure is further streamlined resulting in a significant reduction in implantation time.

"Reduced time in the operating room means less risk for the patient and lower overall hospital costs."

Implanted through minimally invasive surgical procedure, the abiliti system identifies when a person eats or drinks and sends low-level electrical impulses to the stomach, making them to eat less.